A subgroup analysis of JUMP, a phase IIIb, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis in a Brazilian cohort

Autor: Tavares, Renato, Souza, Carmino Antonio De, Paley, Carole, Bouard, Catherine, Tiwari, Ranjan, Pasquini, Ricardo
Zdroj: In Hematology, Transfusion and Cell Therapy January-March 2020 42(1):46-53
Databáze: ScienceDirect